Md. Black et al., On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia, NEUROPHARM, 38(9), 1999, pp. 1299-1306
NADPH-d (nicotinamide-adenine dinucleotide phosphate-diaphorase) neurons ar
e thought to migrate improperly during development in the brains of schizop
hrenic patients. This enzyme is a nitric oxide synthase (NOS). Nitric oxide
(NO) is known to affect neurodevelopmental processes in the CNS. Therefore
, we hypothesized that interference of NO generation during development may
produce some aspects of schizophrenia symptomatology in a rat model. In th
ese experiments, neonatal rats were challenged with a NOS inhibitor (L-nitr
oarginine 1-100 mg/kg s.c.) daily on post-natal days 3-5. L-Nitroarginine (
L-NoArg) treated male rats developed a hypersensitivity to amphetamine in a
dulthood versus vehicle treated controls, whereas female rats did not. Howe
ver, L-NoArg treated female rats developed a hypersensitivity to phencyclid
ine (PCP) at juvenile and adult ages versus vehicle treated controls, where
as male animals did not. L-NoArg treated male rats also had deficits in pre
-pulse inhibition of startle whereas adult female rats did not. The results
are discussed in terms of a new neurodevelopmental model of schizophrenia
and male/female differences inherent in this disease. (C) 1999 Elsevier Sci
ence Ltd. All rights reserved.